{"slideshow_credits": null, "snippet": "Rottapharm said that it expects to price its offering of 50 million shares at 7.25 euros to 9 euros a share, valuing the company at up to 1.8 million euros, or about $2.46 billion.", "abstract": "Rottapharm said that it expects to price its offering of 50 million shares at 7.25 euros to 9 euros a share, valuing the company at up to 1.8 million euros, or about $2.46 billion.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "Chad", "role": "reported", "lastname": "BRAY", "rank": 1, "organization": ""}], "original": "By CHAD BRAY"}, "web_url": "http://dealbook.nytimes.com/2014/07/01/rottapharm-an-italian-drug-maker-sets-price-range-for-i-p-o/", "lead_paragraph": null, "headline": {"main": "Rottapharm, an Italian Drug Maker,  Sets Price Range for I.P.O.", "kicker": "DealBook"}, "_id": "53b2fcad38f0d841fe32d72f", "word_count": "345", "multimedia": [], "pub_date": "2014-07-01T14:22:52Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "glocations", "value": "Italy", "rank": "1"}, {"name": "organizations", "value": "Latham & Watkins LLP", "rank": "5"}, {"name": "organizations", "value": "Morgan Stanley", "rank": "6"}, {"name": "organizations", "value": "Shearman & Sterling", "rank": "7"}, {"name": "organizations", "value": "Borsa Italiana SpA", "rank": "1"}, {"name": "organizations", "value": "Deutsche Bank AG", "rank": "2"}, {"name": "organizations", "value": "Goldman Sachs Group Inc", "rank": "3"}, {"name": "organizations", "value": "JPMorgan Chase & Company", "rank": "4"}, {"name": "subject", "value": "Stocks and Bonds", "rank": "3"}, {"name": "subject", "value": "Initial Public Offerings", "rank": "2"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": "1"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}